Journal of Nuclear Medicine Vol. 46 No. 1 8a-9a
© 2005 by Society of Nuclear Medicine
THIS MONTH IN JNM
Lewis looks at the development and current promise of radiolabeled cyclic peptide ligands for 
vß3 as powerful tools for molecular imaging and targeted radiotherapy of tumors undergoing angiogenesis.
Page 2
Liao and colleagues examine the relative prognostic powers and clinical information provided by 3 assessment techniques in a high-risk population of patients with known or suspected coronary artery disease and discuss possible advantages in combining 2 or more of these approaches.
Page 5
Schinkel and colleagues assess the value and feasibility of pharmacologically induced stress testing in the prediction of mortality and cardiac events in elderly individuals.
Page 12
Brogsitter and colleagues report on the clinical performance of an electrocardiography-gated 3-dimensional 18F-FDG imaging protocol in patients with coronary artery disease and compare results with those from 2-dimensional acquisition.
Page 19
Kluge and colleagues use 18F-FDG SPECT to measure metabolic rates of glucose uptake in myocardium in patients with pulmonary hypertension to identify prognostic parameters for cardiac dysfunction and poor survival.
Page 25
Fukumitsu and colleagues measure and map the distribution of a major subtype A1 adenosine receptor in the human brain using a newly developed radioligand for PET imaging.
Page 32
Kaiboriboon and colleagues apply the technique of composite subtraction ictal SPECT coregistered to MRI to demonstrate typical patterns of hyperperfusion in a group of patients with mesial temporal lobe epilepsy.
Page 38
Xiangsong and colleagues report on a novel approach to evaluating blood perfusion and ammonia metabolism in the pituitary gland and discuss the utility of this method in the diagnosis of hypopituitarism.
Page 44
Salaun and colleagues document the reference range of 18F-FDG uptake in PET imaging of the gastroesophageal junction and gastric antrum in a retrospective study of patients with no history of gastroesophageal disease.
Page 48
Metser and colleagues assessed the role of 18F-FDG PET/CT in the evaluation of solid splenic masses in patients with known malignancy and incidentally found lesions in patients without known malignancy.
Page 52
Lambert and colleagues detail the pharmacokinetics, organ dosimetry, and toxicity identified in a phase 1 study of intraarterial administration of 188Re-HDD/lipiodol, which shows promise in the palliative treatment of hepatocellular carcinoma.
Page 60
Bartel and colleagues investigate the use of a corn oil emulsion as an inexpensive cholecystagogue and alternative to sincalide in the scintigraphic diagnosis of chronic acalculous cholecystitis.
Page 67
Kaufmann and Camici review the ways in which PET measurement of myocardial blood flow has contributed to advanced understanding of cardiac physiology and pathophysiology and look at the promise of new techniques and innovations.
Page 75
Emfietzoglou and colleagues compare absorbed dose profiles within avascular prostate carcinoma spheroids for various ß-, Auger-, and conversion-emitters delivered by liposomes and a monoclonal antibody and discuss the application of results to antibody-based radiotherapy.
Page 89
Simões and colleagues investigate 124I-FIAU PET imaging of reporter gene expression in an isolated heart perfusion model.
Page 98
Piert and colleagues compare 18F-FAZA with the standard hypoxia tracer 18F-FMISO in detection of tumor tissue hypoxia in murine tumor models.
Page 106
Waldherr and colleagues evaluate in an animal model the utility of 18F-FLT PET to noninvasively measure changes in tumor cell proliferation in vivo after kinase inhibitor therapy.
Page 114
Miao and colleagues examine in a mouse model the efficacy of a promising 188Re-labeled peptide for targeted radionuclide therapy of melanoma.
Page 121
Chattopadhyay and colleagues report on the development and evaluation of a novel PET agent for imaging nicotine 4ß2 receptors, which are implicated in the study of Alzheimer’s disease, schizophrenia, substance abuse, lung cancer, and other disorders.
Page 130
Kim and colleagues explore in an animal model the possibility of liver-targeted nuclear imaging with 99mTc-galactosyl–methylated chitosan bound to asialoglycoprotein receptors.
Page 141
Joseph and colleagues assess the role of cytokines in regulating 99mTc-mebrofenin transport and discuss implications for using this process to identify and monitor organ inflammation, including hepatitis, fatty liver disease, allograft rejection, and responses to gene therapy vectors.
Page 146
Govindan and colleagues develop a simple, remote, "1-pot" method for production of a residualizing 131I-labeled monoclonal antibody at levels needed for clinical therapy.
Page 153
Igarashi and colleagues investigate in a rat model whether changes in myocardial uptake of fatty acid tracer after reperfusion subsequent to transient myocardial ischemia are closely related to alterations in intracellular fatty acid oxidation.
Page 160
De Bondt and colleagues test the performance of 4 algorithms that calculate left and right ventricular ejection fractions from tomographic radionuclide ventriculography and discuss clinical implications of these dynamic cardiac models.
Page 165
Higuchi and colleagues compare autoradiographic uptake of BMIPP and 201Tl in assessing serial changes in fatty acid metabolism associated with acute ischemia and reperfusion in rat hearts.
Page 172
Manrique and colleagues determine the effect of perfusion defect and imaging sequence on the evaluation of myocardial stunning with gated perfusion SPECT, using a dynamic mathematic cardiac torso phantom.
Page 176
Pichler and colleagues report a new application of radiolabeled RGD peptides targeting vß3 imaging of delayed-type hypersensitivity reaction in a mouse model of chronic inflammation.
Page 184
| ON THE COVER
The putative antagonist 18F-labeled 5-(3'-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine (nifrolidine) has been found to bind to 4ß2 receptor–rich regions in rats and monkeys, indicating promise as a PET agent. In these images of rhesus monkey brain, correlation of 18F-nifrolidine PET images with MRI templates indicates significant binding in the thalamic regions and significant uptake by the temporal and frontal cortices. The summed images at bottom show that the anteroventral, anteromedial, and ventrolateral thalami are the regions of highest uptake, consistent with the reported distribution of the 4ß2 receptor subtype in rhesus monkeys.
|
Related articles in JNM:
- Hypoxia-Specific Tumor Imaging with 18F-Fluoroazomycin Arabinoside
- Morand Piert, Hans-Jürgen Machulla, Maria Picchio, Gerald Reischl, Sybille Ziegler, Piyush Kumar, Hans-Jürgen Wester, Roswitha Beck, Alexander J.B. McEwan, Leonard I. Wiebe, and Markus Schwaiger
JNM 2005 46: 106-113.
[Abstract]
[Full Text]
- Monitoring Antiproliferative Responses to Kinase Inhibitor Therapy in Mice with 3'-Deoxy-3'-18F-Fluorothymidine PET
- Christian Waldherr, Ingo K. Mellinghoff, Chris Tran, Benjamin S. Halpern, Nora Rozengurt, Arash Safaei, Wolfgang A. Weber, David Stout, Nagichettiar Satyamurthy, Jorge Barrio, Michael E. Phelps, Daniel H. Silverman, Charles L. Sawyers, and Johannes Czernin
JNM 2005 46: 114-120.
[Abstract]
[Full Text]
- Prognostic Stratification Using Dobutamine Stress 99mTc-Tetrofosmin Myocardial Perfusion SPECT in Elderly Patients Unable to Perform Exercise Testing
- Arend F.L. Schinkel, Abdou Elhendy, Elena Biagini, Ron T. van Domburg, Roelf Valkema, Vittoria Rizello, Chiara Pedone, Maarten Simoons, Jeroen J. Bax, and Don Poldermans
JNM 2005 46: 12-18.
[Abstract]
[Full Text]
- Therapeutic Efficacy of a 188Re-Labeled -Melanocyte–Stimulating Hormone Peptide Analog in Murine and Human Melanoma-Bearing Mouse Models
- Yubin Miao, Nellie K. Owen, Darrell R. Fisher, Timothy J. Hoffman, and Thomas P. Quinn
JNM 2005 46: 121-129.
[Abstract]
[Full Text]
- Synthesis and Evaluation of Nicotine 4ß2 Receptor Radioligand, 5-(3'-18F-Fluoropropyl)-3-(2-(S)-Pyrrolidinylmethoxy)Pyridine, in Rodents and PET in Nonhuman Primate
- Sankha Chattopadhyay, Baogang Xue, Daphne Collins, Rama Pichika, Rudy Bagnera, Frances M. Leslie, Bradley T. Christian, Bingzhi Shi, Tanjore K. Narayanan, Steven G. Potkin, and Jogeshwar Mukherjee
JNM 2005 46: 130-140.
[Abstract]
[Full Text]
- Hepatocyte-Targeted Nuclear Imaging Using 99mTc-Galactosylated Chitosan: Conjugation, Targeting, and Biodistribution
- Eun-Mi Kim, Hwan-Jeong Jeong, In-Kyu Park, Chong-Su Cho, Chang-Guhn Kim, and Hee-Seung Bom
JNM 2005 46: 141-145.
[Abstract]
[Full Text]
- Regulation of Hepatobiliary Transport Activity and Noninvasive Identification of Cytokine-Dependent Liver Inflammation
- Brigid Joseph, Kuldeep K. Bhargava, Gene G. Tronco, Vinay Kumaran, Christopher J. Palestro, and Sanjeev Gupta
JNM 2005 46: 146-152.
[Abstract]
[Full Text]
- Clinical-Scale Radiolabeling of a Humanized Anticarcinoembryonic Antigen Monoclonal Antibody, hMN-14, with Residualizing 131I for Use in Radioimmunotherapy
- Serengulam V. Govindan, Gary L. Griffiths, Rhona Stein, Philip Andrews, Robert M. Sharkey, Hans J. Hansen, Ivan D. Horak, and David M. Goldenberg
JNM 2005 46: 153-159.
[Abstract]
[Full Text]
- Evaluation of Fatty Acid Metabolism in Hearts After Ischemia–Reperfusion Injury Using a Dual-Isotope Autoradiographic Approach and Tissue Assay for Metabolites of Tracer
- Norio Igarashi, Takashi Nozawa, Nozomu Fujii, Bun-ichi Kato, Makoto Nonomura, Akira Matsuki, Teruo Nakadate, Akihiko Igawa, Hidetsugu Asanoi, Minoru Inoue, and Hiroshi Inoue
JNM 2005 46: 160-164.
[Abstract]
[Full Text]
- Accuracy of 4 Different Algorithms for the Analysis of Tomographic Radionuclide Ventriculography Using a Physical, Dynamic 4-Chamber Cardiac Phantom
- Pieter De Bondt, Tom Claessens, Bart Rys, Olivier De Winter, Stijn Vandenberghe, Patrick Segers, Pascal Verdonck, and Rudi Andre Dierckx
JNM 2005 46: 165-171.
[Abstract]
[Full Text]
- Time Course of Discordant BMIPP and Thallium Uptake After Ischemia and Reperfusion in a Rat Model
- Takahiro Higuchi, Junichi Taki, Kenichi Nakajima, Seigo Kinuya, Masanobu Namura, and Norihisa Tonami
JNM 2005 46: 172-175.
[Abstract]
[Full Text]
- Effect of Perfusion Pattern and Imaging Sequence on Gated Perfusion SPECT Evaluation of Myocardial Stunning
- Alain Manrique, Anne Hitzel, David Brasse, and Pierre Véra
JNM 2005 46: 176-183.
[Abstract]
[Full Text]
- Imaging of Delayed-Type Hypersensitivity Reaction by PET and 18F-Galacto-RGD
- Bernd J. Pichler, Manfred Kneilling, Roland Haubner, Heidi Braumüller, Markus Schwaiger, Martin Röcken, and Wolfgang A. Weber
JNM 2005 46: 184-189.
[Abstract]
[Full Text]
- 18F-FDG PET for Detecting Myocardial Viability: Validation of 3D Data Acquisition
- Claudia Brogsitter, Thomas Grüning, Reiner Weise, Peter Wielepp, Oliver Lindner, Reiner Körfer, and Wolfgang Burchert
JNM 2005 46: 19-24.
[Abstract]
[Full Text]
- Radiolabeled RGD Peptides Move Beyond Cancer: PET Imaging of Delayed-Type Hypersensitivity Reaction
- Michael R. Lewis
JNM 2005 46: 2-4.
[Full Text]
- Different Mechanisms for Changes in Glucose Uptake of the Right and Left Ventricular Myocardium in Pulmonary Hypertension
- Regine Kluge, Henryk Barthel, Hans Pankau, Anita Seese, Joachim Schauer, Hubertus Wirtz, Hans-Juergen Seyfarth, Joerg Steinbach, Osama Sabri, and Joerg Winkler
JNM 2005 46: 25-31.
[Abstract]
[Full Text]
- Adenosine A1 Receptor Mapping of the Human Brain by PET with 8-Dicyclopropylmethyl-1-11C-Methyl-3-Propylxanthine
- Nobuyoshi Fukumitsu, Kenji Ishii, Yuichi Kimura, Keiichi Oda, Toru Sasaki, Yutaka Mori, and Kiichi Ishiwata
JNM 2005 46: 32-37.
[Abstract]
[Full Text]
- Quantitative Analysis of Cerebral Blood Flow Patterns in Mesial Temporal Lobe Epilepsy Using Composite SISCOM
- Kitti Kaiboriboon, Mary E. Bertrand, Medhat M. Osman, and R. Edward Hogan
JNM 2005 46: 38-43.
[Abstract]
[Full Text]
- Dynamic 13N-Ammonia PET: A New Imaging Method to Diagnose Hypopituitarism
- Zhang Xiangsong, Yue Dianchao, and Tang Anwu
JNM 2005 46: 44-47.
[Abstract]
[Full Text]
- An Analysis of the 18F-FDG Uptake Pattern in the Stomach
- Pierre Y. Salaun, Ravinder K. Grewal, Indukala Dodamane, Henry W. Yeung, Steven M. Larson, and H. William Strauss
JNM 2005 46: 48-51.
[Abstract]
[Full Text]
- Prediction of Death and Nonfatal Myocardial Infarction in High-Risk Patients: A Comparison Between the Duke Treadmill Score, Peak Exercise Radionuclide Angiography, and SPECT Perfusion Imaging
- Lawrence Liao, William T. Smith, IV, Robert H. Tuttle, Linda K. Shaw, R. Edward Coleman, and Salvador Borges-Neto
JNM 2005 46: 5-11.
[Abstract]
[Full Text]
- Solid Splenic Masses: Evaluation with 18F-FDG PET/CT
- Ur Metser, Elka Miller, Ada Kessler, Hedva Lerman, Gennady Lievshitz, Ran Oren, and Einat Even-Sapir
JNM 2005 46: 52-59.
[Abstract]
[Full Text]
- 188Re-HDD/Lipiodol Therapy for Hepatocellular Carcinoma: A Phase I Clinical Trial
- Bieke Lambert, Klaus Bacher, Luc Defreyne, Filip Gemmel, Hans Van Vlierberghe, Jae Min Jeong, Rudi A. Dierckx, Christophe Van de Wiele, Hubert Thierens, and Filip De Vos
JNM 2005 46: 60-66.
[Abstract]
[Full Text]
- Corn Oil Emulsion: A Simple Cholecystagogue for Diagnosis of Chronic Acalculous Cholecystitis
- Twyla B. Bartel, Malik E. Juweid, James A. Ponto, and Michael M. Graham
JNM 2005 46: 67-74.
[Abstract]
[Full Text]
- Myocardial Blood Flow Measurement by PET: Technical Aspects and Clinical Applications
- Philipp A. Kaufmann and Paolo G. Camici
JNM 2005 46: 75-88.
[Full Text]
- Liposome-Mediated Radiotherapeutics Within Avascular Tumor Spheroids: Comparative Dosimetry Study for Various Radionuclides, Liposome Systems, and a Targeting Antibody
- Dimitris Emfietzoglou, Kostas Kostarelos, Alexandros Papakostas, Wei-Hong Yang, Åse Ballangrud, Hong Song, and George Sgouros
JNM 2005 46: 89-97.
[Abstract]
[Full Text]
